Table 1.
Position in pol | ART class | RAM residuea | Shortest mutational pathway | |
---|---|---|---|---|
Subtype B | Non-B subtypeb | |||
PR V82 | PI | S T |
GTC→TCC GTC→AGC |
G, CRF14: ATC→AGC G, CRF14: ATC→ACC |
RT D67 | NRTI | N | GAC→AAC | CRF04: AAC |
RT K70 | NRTI | G R |
AAA→GGA AAA→AGA |
CRF04: AGA→GGA CRF04: AGA |
RT V106 | NNRTI | M | GTA→ATG | C: GTG→ATG |
RT V179 | NNRTI | E | GTT→GAG | G, CRF02, CRF14: GTG→GAG |
RT T215 | NRTI | F Y |
ACC→TTC ACC→TAC |
CRF04: TCC→TTC CRF04: TCC→TAC |
IN E157 | INI | Q | GAA→CAA | CRF03: CAA |
NOTE. Consensus sequences based on the reference sets from Los Alamos National Laboratory (http://www.hiv.lanl.gov). ART, antiretroviral therapy; CRF, circulating recombinant form; IN, integrase; INI, integrase inhibitor; NNRTI, nonnucleoside reverse-transcriptase inhibitor; NRTI, nucleoside reverse-transcriptase inhibitor; PI, protease inhibitor; PR, protease coding region; RT, reverse-transcriptase coding region.
Single-letter amino acid code.
Non-B subtypes are underlined.